Photronics Reports First Quarter Fiscal 2012 Results
• Quarterly sales of
• GAAP net income of
• Non-GAAP EPS of
• EBITDA of
• Net cash improves
Constantine ("Deno") Macricostas,
"We did see strength in high-end semiconductor photomask sales as leading edge customers continued to invest in new designs during the cycle," continued Macricostas. "We increased high end IC sales 6% sequentially and 98% over the same period last year as our investments at the leading edge partially offset the slowdown in the mainstream business during the period. Our technology leadership, coupled with a lean and flexible operating structure, enabled us to deliver on our expectations for the quarter and should drive solid earnings growth when the market returns."
Sales for the first quarter of fiscal 2012 were
GAAP net income attributable to
The section below entitled "Non-GAAP Financial Measures"
provides a definition and information about the use of non-GAAP
financial measures in this press release, and the attached financial
supplement reconciles non-GAAP financial information with
Non-GAAP Financial Measures
Non-GAAP net income attributable to
- Consolidation and restructuring charges in the first quarter of fiscal 2012 are excluded because they are not a part of ongoing operations.
- Impact of warrants is excluded because it does not affect cash earnings.
The presentation of this financial information should not be considered
in isolation or as a substitute for the financial information prepared
and presented in accordance with accounting principles generally
accepted in
A conference call with investors and the media to discuss these results
is scheduled for
# # #
The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" for forward-looking statements made by or on behalf of
05-2012
PLAB — E
|
|||||||||
Reconciliation of GAAP to Non-GAAP Financial Information |
|||||||||
(in thousands, except per share data) | |||||||||
(Unaudited) | |||||||||
Three Months Ended | |||||||||
|
January 30, | ||||||||
2012 | 2011 | ||||||||
Reconciliation of GAAP to Non-GAAP Net Income |
|||||||||
Attributable to |
|||||||||
GAAP net income attributable to |
$ | 4,268 | $ | 12,111 | |||||
(a) Consolidation and restructuring charges, net of tax | 1,118 | - | |||||||
(b) Impact of warrants, net of tax | (94 | ) | 75 | ||||||
Non-GAAP net income attributable to |
$ | 5,292 | $ | 12,186 | |||||
Reconciliation of GAAP to Non-GAAP Net Income |
|||||||||
Applicable to Common Shareholders |
|||||||||
Weighted average number of diluted shares outstanding | |||||||||
GAAP | 60,930 | 66,411 | |||||||
Non-GAAP | 60,856 | 66,411 | |||||||
Net income per diluted share | |||||||||
GAAP | $ | 0.07 | $ | 0.20 | |||||
Non-GAAP | $ | 0.09 | $ | 0.20 |
(a) Represents consolidation and restructuring charges primarily related to the announced |
restructuring in |
(b) Represents financing expenses related to warrants, which are recorded in other income |
(expense), net. |
|
|||||||||||
Condensed Consolidated Statements of Income |
|||||||||||
(in thousands, except per share amounts) | |||||||||||
(Unaudited) | |||||||||||
Three Months Ended | |||||||||||
|
January 30, | ||||||||||
2012 | 2011 | ||||||||||
Net sales | $ | 112,154 | $ | 120,823 | |||||||
Costs and expenses: | |||||||||||
Cost of sales | (86,696 | ) | (90,229 | ) | |||||||
Selling, general and administrative | (11,325 | ) | (10,713 | ) | |||||||
Research and development | (4,444 | ) | (3,771 | ) | |||||||
Consolidation, restructuring and related charges | (1,118 | ) | - | ||||||||
Operating income | 8,571 | 16,110 | |||||||||
Other income (expense), net | (409 | ) | 957 | ||||||||
Income before income taxes | 8,162 | 17,067 | |||||||||
Income tax provision | (3,321 | ) | (3,483 | ) | |||||||
Net income | 4,841 | 13,584 | |||||||||
Net income attributable to noncontrolling interests | (573 | ) | (1,473 | ) | |||||||
Net income attributable to |
$ | 4,268 | $ | 12,111 | |||||||
Earnings per share: | |||||||||||
Basic | $ | 0.07 | $ | 0.23 | |||||||
Diluted | $ | 0.07 | $ | 0.20 | |||||||
Weighted-average number of common shares | |||||||||||
outstanding: | |||||||||||
Basic | 59,817 | 53,817 | |||||||||
Diluted | 60,930 | 66,411 | |||||||||
|
|||||||||||
Condensed Consolidated Balance Sheets |
|||||||||||
(in thousands) | |||||||||||
(Unaudited) | |||||||||||
|
October 30, | ||||||||||
2012 | 2011 | ||||||||||
Assets |
|||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 201,800 | $ | 189,928 | |||||||
Accounts receivable | 84,092 | 85,540 | |||||||||
Inventories | 21,626 | 22,100 | |||||||||
Other current assets | 8,137 | 7,639 | |||||||||
Total current assets | 315,655 | 305,207 | |||||||||
Property, plant and equipment, net | 359,814 | 368,680 | |||||||||
Investment in joint venture | 80,365 | 79,984 | |||||||||
Intangible assets, net | 41,194 | 42,462 | |||||||||
Other assets | 22,663 | 21,521 | |||||||||
$ | 819,691 | $ | 817,854 | ||||||||
Liabilities and Equity |
|||||||||||
Current liabilities: | |||||||||||
Current portion of long-term borrowings | $ | 5,529 | $ | 5,583 | |||||||
Accounts payable and accrued liabilities | 89,638 | 90,318 | |||||||||
Total current liabilities | 95,167 | 95,901 | |||||||||
Long-term borrowings | 151,257 | 152,577 | |||||||||
Other liabilities | 8,821 | 9,620 | |||||||||
Equity | 564,446 | 559,756 | |||||||||
$ | 819,691 | $ | 817,854 | ||||||||
|
||||||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||||||
(in thousands) | ||||||||||||
(Unaudited) | ||||||||||||
Three Months Ended | ||||||||||||
|
January 30, | |||||||||||
2012 | 2011 | |||||||||||
Cash flows from operating activities: | ||||||||||||
Net income | $ | 4,841 | $ | 13,584 | ||||||||
Adjustments to reconcile net income to net cash | ||||||||||||
provided by operating activities: | ||||||||||||
Depreciation and amortization | 22,667 | 23,189 | ||||||||||
Changes in assets and liabilities and other | 6,527 | 4,882 | ||||||||||
Net cash provided by operating activities | 34,035 | 41,655 | ||||||||||
Cash flows from investing activities: | ||||||||||||
Purchases of property, plant and equipment | (18,127 | ) | (19,120 | ) | ||||||||
Investment in joint venture | (400 | ) | (3,999 | ) | ||||||||
Other | (1,602 | ) | - | |||||||||
Net cash used in investing activities | (20,129 | ) | (23,119 | ) | ||||||||
Cash flows from financing activities: | ||||||||||||
Repayments of long-term borrowings | (999 | ) | (24,346 | ) | ||||||||
Repurchase of common stock of subsidiary | (885 | ) | - | |||||||||
Proceeds from share-based payments | 233 | 159 | ||||||||||
Proceeds from long-term borrowings | - | 17,000 | ||||||||||
Net cash used in financing activities | (1,651 | ) | (7,187 | ) | ||||||||
Effect of exchange rate changes on cash | (383 | ) | 2,429 | |||||||||
Net increase in cash and cash equivalents | 11,872 | 13,778 | ||||||||||
Cash and cash equivalents, beginning of period | 189,928 | 98,945 | ||||||||||
Cash and cash equivalents, end of period | $ | 201,800 | $ | 112,723 | ||||||||
Supplemental disclosure of cash flow information: | ||||||||||||
Change in accrual for purchases of property, plant and equipment | $ | 5,159 | $ | 13,273 |
Vice President,
Investor Relations & Marketing
pbroadbent@photronics.com
Source:
News Provided by Acquire Media